What is Good-Lite?
Established in 1930, Good-Lite has cultivated a reputation for excellence in the production of precision vision screening instruments and diagnostic charts. The company serves as the primary manufacturer and distributor of the globally recognized Lea Test System, which encompasses specialized tools for assessing cortical visual function, stereo vision, and color perception. By integrating high-contrast and low-contrast testing methodologies, Good-Lite remains an essential partner for clinical practitioners worldwide, ensuring that diagnostic standards remain consistent across diverse patient populations. Their market position is defined by a unique blend of historical legacy and technical innovation in pediatric and adult vision assessment.
How much funding has Good-Lite raised?
Good-Lite has raised a total of $349K across 2 funding rounds:
Debt
$150K
Debt
$199K
Debt (2020): $150K with participation from PPP
Debt (2021): $199K led by PPP
Key Investors in Good-Lite
PPP
Public-Private Partnership
What's next for Good-Lite?
The recent influx of capital positions Good-Lite to further optimize its supply chain and expand the reach of its diagnostic portfolio. As the company transitions through this late-stage growth phase, the focus will likely shift toward scaling the distribution of its proprietary testing systems and potentially integrating digital health solutions into its traditional hardware offerings. By leveraging this financial backing, Good-Lite is well-equipped to sustain its competitive advantage, ensuring that its diagnostic tools continue to meet the evolving regulatory and clinical requirements of the global optometry and ophthalmology sectors.
See full Good-Lite company page
